A Response to "Equipoise Is No Longer a Major Consideration in the Ethical Evaluation of Phase 3 Randomized Controlled Trials Involving Precision Oncology Approaches in NSCLC".
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Year: December 16, 2024